Clinical trials are vital in testing the safety and efficacy of new treatments and approaches. Our researchers are national leaders in multiple national cooperative groups, including the NRG and Alliance Groups, and are principal investigators on cutting-edge treatment trials.

Jyoti Mayadev MD

NRG Cooperative Group

Anti PD-L1 (Atezolizumab) as an Immune Primer and Concurrently with Extended Field Chemoradiotherapy for Node Positive Locally Advanced Cervical Cancer

Loren Mell MD

NRG Cooperative Group

Phase II/III Trial of RT Concurrent Durvalumab vs. RT with Concurrent Cetuximab in Patients with Cisplatin-ineligible Head and Neck Cancer

James Urbanic MD

Alliance Cooperative Group

Phase 1 Study of Accelerated Hypofractionated RT withi Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer; CALGB 31102

Catheryn Yashar MD

NRG Cooperative Group

Adjuvant Pelvic RT versus Vaginal Brachytherapy plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.

Multiple other RMAS faculty oversee Investigator-Initiated Trials (IIT) at the Moores Cancer Center, many of which are not available elsewhere.

Jona Hattangadi-Gluth MD

Prospective Study of Neurocognitive Function in Brain Tumor Patients Undergoing Radiation Therapy

Tyler Seibert MD

Whole Body RSI Magnetic Resonance Imaging in High Risk Prostate Cancer

Jim Murphy MD

SBRT in Pancreatic Cancer

Andrew Sharabi MD

Randomized Phase II Trial of Checkpoint Blockade Immunotherapy +/- SBRT

Todd Atwood PhD

Randomized Trial of Physics Direct Patient Initiative